Found: 20
Select item for more details and to access through your institution.
Real world usage of PCC to "rapidly" correct warfarin induced coagulopathy.
- Published in:
- Blood Transfusion (17232007), 2013, v. 11, n. 4, p. 500, doi. 10.2450/2012.0113-12
- By:
- Publication type:
- Article
Agreement between one stage and chromogenic assays in samples from patients receiving recombinant porcine FVIII (Obizur, Susoctocog‐alfa).
- Published in:
- International Journal of Laboratory Hematology, 2024, v. 46, n. 1, p. 135, doi. 10.1111/ijlh.14181
- By:
- Publication type:
- Article
The combination of emicizumab and recombinant factor VIII in plasma: Which assays can we use for accurate measurement?
- Published in:
- International Journal of Laboratory Hematology, 2023, v. 45, n. 3, p. 368, doi. 10.1111/ijlh.14021
- By:
- Publication type:
- Article
Measurement of antifactor VIII antibody titre in the presence of emicizumab; Use of chromogenic Bethesda assays.
- Published in:
- 2021
- By:
- Publication type:
- Case Study
Measurement of extended half‐life recombinant factor IX products in clinical practice.
- Published in:
- International Journal of Laboratory Hematology, 2019, v. 41, n. 2, p. e46, doi. 10.1111/ijlh.12953
- By:
- Publication type:
- Article
Management of acute pulmonary embolism.
- Published in:
- British Journal of Hospital Medicine (17508460), 2015, v. 76, n. 10, p. C150, doi. 10.12968/hmed.2015.76.10.C150
- By:
- Publication type:
- Article
Von Willebrand factor assays in patients with acquired immune thrombotic thrombocytopenia purpura treated with caplacizumab.
- Published in:
- British Journal of Haematology, 2022, v. 197, n. 3, p. 349, doi. 10.1111/bjh.18080
- By:
- Publication type:
- Article
Oral anticoagulant agent-associated bleeding events reporting system ( ORANGE) study.
- Published in:
- British Journal of Haematology, 2014, v. 167, n. 2, p. 274, doi. 10.1111/bjh.12968
- By:
- Publication type:
- Article
Oral anticoagulant agent-associated bleeding events reporting system (ORANGE) study.
- Published in:
- British Journal of Haematology, 2014, v. 165, n. 5, p. 1, doi. 10.1111/bjh.12968
- By:
- Publication type:
- Article
Innovative ways of responding to the information needs of people with MS.
- Published in:
- British Journal of Nursing, 2005, v. 14, n. 14, p. 754, doi. 10.12968/bjon.2005.14.14.18551
- By:
- Publication type:
- Article
Treating uncontrollable laughter or crying in people with multiple sclerosis.
- Published in:
- 2013
- By:
- Publication type:
- Opinion
Guidelines for supportive care in multiple myeloma 2011.
- Published in:
- British Journal of Haematology, 2011, v. 154, n. 1, p. 76, doi. 10.1111/j.1365-2141.2011.08574.x
- By:
- Publication type:
- Article
High concentrations of coagulation factor VIII and thrombosis: is the factor VIII-binding domain of von Willebrand factor implicated?
- Published in:
- British Journal of Haematology, 2001, v. 113, n. 3, p. 655, doi. 10.1046/j.1365-2141.2001.02830.x
- By:
- Publication type:
- Article
Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient.
- Published in:
- Journal of Thrombosis & Thrombolysis, 2010, v. 29, n. 2, p. 171, doi. 10.1007/s11239-009-0412-5
- By:
- Publication type:
- Article
An expert consensus to define how higher standards of equitable care for von Willebrand disease can be achieved in the UK and Republic of Ireland.
- Published in:
- Haemophilia, 2023, v. 29, n. 3, p. 819, doi. 10.1111/hae.14765
- By:
- Publication type:
- Article
Cross‐reacting recombinant porcine FVIII inhibitors in patients with acquired haemophilia A.
- Published in:
- Haemophilia, 2020, v. 26, n. 6, p. 1181, doi. 10.1111/hae.14162
- By:
- Publication type:
- Article
Effects of emicizumab on APTT, one‐stage and chromogenic assays of factor VIII in artificially spiked plasma and in samples from haemophilia A patients with inhibitors.
- Published in:
- Haemophilia, 2020, v. 26, n. 3, p. 536, doi. 10.1111/hae.13990
- By:
- Publication type:
- Article
Multiple sclerosis: understanding a complex neurological condition.
- Published in:
- Nursing Standard, 2010, v. 24, n. 28, p. 50, doi. 10.7748/ns.24.28.50.s47
- By:
- Publication type:
- Article
Caution in Using the Activated Partial Thromboplastin Time to Monitor Argatroban in COVID-19 and Vaccine-Induced Immune Thrombocytopenia and Thrombosis (VITT).
- Published in:
- Clinical & Applied Thrombosis/Hemostasis, 2021, v. 27, p. 1, doi. 10.1177/10760296211066945
- By:
- Publication type:
- Article
Factor V Leiden and the common haemochromatosis mutation HFE C282Y: is there an association in familial venous thromboembolic disease?
- Published in:
- British Journal of Haematology, 1999, v. 107, n. 1, p. 210, doi. 10.1046/j.1365-2141.1999.01663.x
- By:
- Publication type:
- Article